Duoneb and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duoneb (albuterol sulfate; ipratropium bromide) and Micro-k (potassium chloride). Common drug interactions include respiratory failure among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Duoneb and Micro-k. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 30, 2026

29 people who take Duoneb and Micro-k together, and have interactions are studied.

Duoneb and Micro-k drug interactions.

What are the common drug interactions of Duoneb and Micro-K, by gender? *:

female:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Anaemia (lack of blood)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Back pain
  6. Balance disorder
  7. Blood pressure diastolic decreased
  8. Burns third degree
  9. Cardiac arrest
  10. Cardiogenic shock (inadequate circulation of blood)

male:

  1. Pneumonia
  2. Anxiety
  3. Lethargy (tiredness)
  4. Pain
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Anaemia (lack of blood)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Deafness
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Duoneb and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  3. Bipolar disorder (mood disorder)
  4. Blood cholesterol increased
  5. Cellulitis (infection under the skin)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Depression
  9. Diabetes mellitus inadequate control
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

60+:

  1. Cardiac failure congestive
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Myalgia (muscle pain)
  4. Pain
  5. Confusional state
  6. Deformity (disfigurement)
  7. Diarrhoea
  8. Dyspnoea (difficult or laboured respiration)
  9. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  10. Haemorrhagic anaemia (anaemia due to excessive bleeding)

What are the existing conditions these people have? *

  1. Heart Rate Irregular: 6 people, 20.69%
  2. Pain: 5 people, 17.24%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 13.79%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 13.79%
  5. Dyspnea (difficult or laboured breathing): 3 people, 10.34%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.34%
  7. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 6.90%
  8. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 6.90%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.90%
  10. High Blood Pressure: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Duoneb and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duoneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide and potassium chloride (the active ingredients of Duoneb and Micro-k, respectively), and Duoneb and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: